Anti-Metastatic and Anti-Tumor Growth Effects of Origanum majorana on Highly Metastatic Human Breast Cancer Cells: Inhibition of NFκB Signaling and Reduction of Nitric Oxide Production

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Al Dhaheri, Yusra ^a   Attoub, Samir ^a   Arafat, Kholoud ^a   AbuQamar, Synan ^a   Viallet, Jean ^b   Saleh, Alaaeldin ^c   Al Agha, Hala ^c   Eid, Ali ^c   Iratni, Rabah ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b INSERM   (France)

^c Qatar University   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; ORIGANUM MAJORANA EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UROKINASE RECEPTOR; UVOMORULIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOSYNTHESIS; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL ACTIVATION; CELL ADHESION; CELL AGGREGATION; CELL ASSAY; CELL MIGRATION; CELL NUCLEUS; CELL STRAIN; CELL STRAIN MDA MB 231; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG ISOLATION; EMBRYO; ENZYME ACTIVITY; HUMAN; HUMAN CELL; METASTASIS INHIBITION; METASTASIS POTENTIAL; NONHUMAN; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR INVASION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WOUND HEALING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL PROLIFERATION; CELLS, CULTURED; CHICK EMBRYO; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOPLASM METASTASIS; NF-KAPPA B; NITRIC OXIDE; ORIGANUM; PLANT EXTRACTS; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ORIGANUM MAJORANA;

EID: 84880010799     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068808     Document Type: Article

References (66)

1. Ling H, Yang H, Tan SH, Chui WK, Chew EH, (2010) 6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-kB activation. Br J Pharmacol, 161: 763-1777.
2. Yang HL, Kuo YH, Tsai CT, Huang YT, Chen SC, et al. (2011) Anti-metastatic activities of Antrodia camphorata against human breast cancer cells mediated through suppression of the MAPK signaling pathway. Food Chem Toxicol, 49: 290-298. doi:10.1016/j.fct.2010.10.031. PubMed: 21056076.
3. Li F, Li C, Zhang H, Lu Z, Li Z, et al. (2012) VI-14, a novel flavonoid derivative, inhibits migration and invasion of human breast cancer cells. Toxicology and Applied Pharmacology Toxicol Appl Pharmacol, 261: 217-226. PubMed: 22538171.
4. Yachida S, Jones S, Bozic I, Antal T, Leary R, et al. (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114-1117. doi:10.1038/nature09515. PubMed: 20981102.
5. Baranwal S, Alahari SK, (2009) Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun, 19384:: 6-11. PubMed: 19379710.
6. Corn PG, Smith BD, Ruckdeschel ES, Douglas D, Baylin SB, et al. (2000) E-Cadherin Expression Is Silenced by 5' CpG Island Methylation in Acute Leukemia. Clin Cancer Res, 6: 4243-4248. PubMed: 11106238.
7. Park JS, Kim KM, Kim MH, Chang HJ, Baek MK, et al. (2009) Resveratrol inhibits tumor cell adhesion to endothelial cells by blocking ICAM-1 expression. Anticancer Res, 29: 355-362. PubMed: 19331173.
8. Rosette C, Roth RB, Oeth P, Braun A, Kammerer S, et al. (2005) Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis, 26(5):: 943-950. PubMed: 15774488.
9. Reuben SC, Gopalan A, Petit DM, Bishayee A, (2012) Modulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer. Mol Nutr Food Res, 56: 14-29. doi:10.1002/mnfr.201100619. PubMed: 22125182.
10. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, et al. (1993) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res, 53: 4727-4735. PubMed: 8402650.
11. Rose P, Huang Q, Ong CN, Whiteman M, (2005) Broccoli and watercress suppress matrix metalloproteinase-9 activity and invasiveness of human MDA-MB-231 breast cancer cells. Toxicol Appl Pharmacol, 209: 105-113. doi:10.1016/j.taap.2005.04.010. PubMed: 15953625.
12. Pacheco MM, Mourão M, Mantovani EB, Nishimoto IN, Brentani MM, (1998) Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations. Clin Exp Metastasis, 16: 577-585]. doi:10.1023/A:1006580415796. PubMed: 9932604.
13. Przybylowska K, Kluczna A, Zadrozny M, Krawczyk T, Kulig A, et al. (2006) Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast Cancer Res Treat, 95: 65-72]. doi:10.1007/s10549-005-9042-6. PubMed: 16267613.
14. Garbett EA, Reed MWR, Stephenson TJ, Brown NJ, (2000) Proteolysis in human breast cancer. J Clin Pathol Mol Pathol, 53: 99-106]. doi:10.1136/mp.53.2.99. PubMed: 10889910.
15. Adams LS, Phung S, Yee N, Seeram NP, Li L, et al. (2010) Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Cancer Res, 70: 3594-3605. doi:10.1158/1538-7445.AM10-3594. PubMed: 20388778.
16. Yodkeeree S, Ampasavate C, Sung B, Aggarwal BB, Limtrakul P, (2010) Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line. Eur J Pharmacol, 627: 8-15. doi:10.1016/j.ejphar.2009.09.052. PubMed: 19818349.
17. Lee HS, Seo EY, Kang NE, Kim WK, (2008) [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J Nutr Biochem, 9: 313-319. PubMed: 17683926.
18. Novak U, Cocks BG, Hamilton JA, (1991) A labile repressor acts through the NFkB-like binding sites of the human urokinase gene. Nucleic Acids Res, 19: 3389-3393. doi:10.1093/nar/19.12.3389. PubMed: 1905804.
19. Sliva D, Rizzo MT, English D, (2002) Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator. J Biol Chem 277: 3150-3157. doi:10.1074/jbc.M109579200. PubMed: 11689575.
20. Wang Y, Dang J, Wang H, Allgayer H, Murrell GA, Boyd D, (2000) Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor. Eur J Biochem 267: 3248-3254. doi:10.1046/j.1432-1327.2000.01350.x. PubMed: 10824110.
21. Lerebours F, Vacher S, Andrieu C, Espie M, Marty M, et al. (2008) NF-kappaB genes have a major role in Inflammatory Breast Cancer BMC Cancer, 8: 41 doi:10.1186/1471-2407-8-41.
22. Bigelow RL, Cardelli JA, (2006) The green tea catechins, (-)-epigallocatechin-3-gallate (EGCG) and (-)-epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene, 25: 1922-1930. doi:10.1038/sj.onc.1209227. PubMed: 16449979.
23. Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH, (2008) Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and β4 integrin function in MDA-MB-231 breast cancer cells. Toxicol Appl Pharmacol, 226: 178-191. doi:10.1016/j.taap.2007.09.013. PubMed: 17961621.
24. Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyd FP Jr, Ho NW, (2002) Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun, 298: 603-612. doi:10.1016/S0006-291X(02)02496-8. PubMed: 12408995.
25. Jiang J, Grieb B, Thyagarajan A, Sliva D, (2008) Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-κB signaling. Int J Mol Med, 21: 577-584. PubMed: 18425349.
26. Vàgi E, Rapavi E, Hadolin M, Vàsàrhelyiné Perédi K, Balàzs A, et al. (2005) Phenolic and triterpenoid antioxidants from Origanum majorana L. herb and extracts obtained with different solvents. Agric Food Chem, 53: 17-21. doi:10.1021/jf048777p.
27. Al-Harbi NO, (2011) Effect of marjoram extract treatment on the cytological and biochemical changes induced by cyclophosphamide in mice. J Med Plants Res, 5(23):: 5479-5485.
28. Miron TL, Plaza M, Bahrim G, Ibariez E, Herrero M, (2011) Chemical composition of biocactive pressurized extracts of Romanian aromatic plants. J Chromatogr A. 1218: 4918-4927. doi:10.1016/j.chroma.2010.11.055. PubMed: 21163488.
29. Leeja L, Thoppil JE, (2007) Antimicrobial activity of methanol extract of Origanum majorana L. (Sweet marjoram). J Environ Biol, 28(1):: 145-146. PubMed: 17718003.
30. El-Ashmawy IM, El-Nahas AF, Salama OM, (2005) Protective effect of volatile oil, alcoholic and aqueous extracts of Origanum majorana on lead acetate toxicity in mice. Basic Clin Pharmacol Toxicol, 97(4):: 238-243. doi:10.1111/j.1742-7843.2005.pto_136.x. PubMed: 16176560.
31. Al Dhaheri Y, Eid A, AbuQamar S, Attoub S, Khasawneh M, et al. (2013) Mitotic Arrest and Apoptosis in Breast Cancer Cells Induced by Origanum majorana Extract: Upregulation of TNF-a and Downregulation of Survivin and Mutant p53. PLOS ONE, 8(2):: e56649. doi:10.1371/journal.pone.0056649. PubMed: 23451065.
32. Prudent R, Vassal-Stermann E, Nguyen CH, Mollaret M, Viallet J, et al. (2013) Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities. Br J Pharmacol. 168: 673-85.
33. Attoub S, Hassan AH, Vanhoecke B, Iratni R, Takahashi T, et al. (2011) Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolinin human epithelioid cancer cells. Eur J Pharmacol 651: 18-25. doi:10.1016/j.ejphar.2010.10.063. PubMed: 21074525.
34. Meromsky L, Lotan R, Raz A, (1986) Implications of endogenous tumor cell surface lectins as mediators of cellular interactions and lung colonization Cancer Res. 46:5270-5.
35. Zen K, Liu D-Q, Guo Y-L, Wang C, Shan J, et al. (2008) CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration. PLOS ONE 3(3):: e1826. doi:10.1371/journal.pone.0001826. PubMed: 18350162.
36. Kleiner DE, Stetler-Stevenson WG, (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218: 325-329. doi:10.1006/abio.1994.1186. PubMed: 8074288.
37. Liu YN, Lee WW, Wang CY, Chao TH, Chen Y, et al. (2005) Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene 24: 8277-8290. doi:10.1038/sj.onc.1208991. PubMed: 16116478.
38. Green CE, Liu T, Montel V, Hsiao G, Lester RD, et al. (2009) Chemoattractant Signaling between Tumor Cells and Macrophages Regulates Cancer Cell Migration, Metastasis and Neovascularization. PLOS ONE 4(8):: e6713. doi:10.1371/journal.pone.0006713. PubMed: 19696929.
39. Jadeski LC, Hum KO, Chakraborty C, Lala PK, (2000) Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer. 86(1):: 30-39. doi:10.1002/(SICI)1097-0215(20000401)86:1. PubMed: 10728591.
40. Vakkala M, Kahlos K, Lakari E, Pääkkö P, Kinnula V, et al. (2000) Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. Clin Cancer Res 6: 2408-2416. PubMed: 10873093.
41. Switzer CH, Glynn SA, Ridnour LA, Cheng RY, Vitek MP, et al. (2011) Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer. Trends Pharmacol Sci 32(11):: 644-651. doi:10.1016/j.tips.2011.07.001. PubMed: 21893353.
42. Gu Y-H, Leonard J, (2006) In vitro effects on proliferation, apoptosis and colony inhibition in ER-dependent and ER independent human breast cancer cells by selected mushroom species. Oncol Rep 15: 417-423. PubMed: 16391863.
43. Teiten M-H, Gaascht F, Eifes S, Dicato M, Diederich M, (2010) Chemopreventive potential of curcumin in prostate cancer. Genes Nutr 5: 61-74. doi:10.1007/s12263-009-0152-3. PubMed: 19806380.
44. Kuno T, Tsukamoto T, Hara A, Tanaka T, (2012) Cancer chemoprevention through the induction of apoptosis by natural compounds. Biophys Chem 3: 156-173. doi:10.4236/jbpc.2012.32018.
45. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, et al. (1995) E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14: 6107-6115. PubMed: 8557030.
46. Mohammadizadeh F, Ghasemibasir H, Rajabi P, Naimi A, Eftekhari A, et al. (2009) Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma. Cancer Biomark 5: 1-8. doi:10.3233/CBM-2009-0551. PubMed: 19242056.
47. Kowalski PJ, Rubin MA, Kleer CG, (2003) E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res;5(6):: R217-R222. doi:10.1186/bcr651. PubMed: 14580257.
48. Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, et al. (2008) Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene. 27: 7274-7284. doi:10.1038/onc.2008.333. PubMed: 18806826.
49. Kim NH, Kim SN, Kim YK, (2011) Involvement of HDAC1 in E-cadherin expression in prostate cancer cells; its implication for cell motility and invasion. Biochem Biophys Res Commun 404: 915-921. doi:10.1016/j.bbrc.2010.12.081. PubMed: 21184735.
50. Tsimogiannis D, Stavrakaki M, Oreopoulou V, (2006) Isolation and characterisation of antioxidant components from Oregano (Origanum heracleoticum). Int J Food Sci Technol 41: 39-48. doi:10.1111/j.1365-2621.2006.01259.x.
51. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, et al. (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 284: 67-68. doi:10.1038/284067a0. PubMed: 6243750.
52. Gialeli C, Theocharis AD, Karamanos NK, (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacologicaltargeting. FEBS J 278: 16-27. Review. doi:10.1111/j.1742-4658.2010.07919.x. PubMed: 21087457.
53. Bachmeier BE, Nerlich AG, Lichtinghagen R, Sommerhoff CP, (2001) Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. Anticancer Res 21: 3821-3828. PubMed: 11911253.
54. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ, (1995) Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376: 517-519. doi:10.1038/376517a0. PubMed: 7543654.
55. Nizamutdinova IT, Lee GW, Lee JS, Cho MK, Son KH, et al. (2008) Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules. Carcinogenesis. 29: 1885-1892. doi:10.1093/carcin/bgn151. PubMed: 18586687.
56. Schröder C, Witzel I, Müller V, Krenkel S, Wirtz RM, et al. (2011) Prognostic value of intercellular adhesion molecule. ICAM-1 expression in breast cancer. J Cancer Res Clin Oncol 2011 137:1193-201.
57. Kerbel R, Folkman J, (2002) Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2: 727-739. doi:10.1038/nrc905. PubMed: 12360276.
58. Kerbel RS, (2006) Antiangiogenic therapy: a universal chemosensitization strategy for cancer? Science. 312: 1171-1175. doi:10.1126/science.1125950. PubMed: 16728631.
59. Relf M, LeJeune S, Scott PA, Fox S, Smith K, et al. (1997) Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57: 963-969. PubMed: 9041202.
60. Lee YJ, Lin WL, Chen NF, Chuang SK, Tseng TH, (2012) Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice. Eur J Med Chem 56: 361-367. doi:10.1016/j.ejmech.2012.07.041. PubMed: 22926226.
61. Li C, Guo S, Shi, Tiemei (2102) Role of NF-κB activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells. Cell Biochemistry and function. Cell Biochem Funct. doi:10.1002/cbf.2899.
62. Perkins ND, (2012) The diverse and complex roles of NF-κB subunits in cancer. Nat Rev Cancer 12: 121131. PubMed: 22257950.
63. Muntané J, De la Mata M, (2010) Nitric oxide and cancer. World J Hepatol 2: 337-344. doi:10.4254/wjh.v2.i9.337. PubMed: 21161018.
64. Wang C, Trudel LJ, Wogan GN, Deen WM, (2003) Thresholds of nitric oxide-mediated toxicity in human lymphoblastoid cells. Chem Res Toxicol 16: 1004-1013. doi:10.1021/tx0340448. PubMed: 12924928.
65. Ambs S, Merriam WG, Ogunfusika MO, Bennett WP, Ishibe N, et al. (1998) p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med 4: 1371-1376. doi:10.1038/3957. PubMed: 9846573.
66. Glynn SA, Boersma BJ, Dorsey TH, Yi M, Yfantis HG, et al. (2010) Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. J Clin Invest 120: 3843-3854. doi:10.1172/JCI42059. PubMed: 20978357.